These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24228478)

  • 21. [Definition of treatment-refractory obsessive-compulsive disorder based on cognitive behavioral therapy].
    Shimizu E
    Seishin Shinkeigaku Zasshi; 2013; 115(9):975-80. PubMed ID: 24228475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive-compulsive disorder: a critical review of therapeutic perspectives.
    Schruers K; Koning K; Luermans J; Haack MJ; Griez E
    Acta Psychiatr Scand; 2005 Apr; 111(4):261-71. PubMed ID: 15740462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic treatment in obsessive-compulsive disorder: a literature review.
    Keuneman RJ; Pokos V; Weerasundera R; Castle DJ
    Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
    Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance and refractoriness in obsessive-compulsive disorder].
    Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy].
    Todorov C
    Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of obsessive-compulsive disorder.
    Simpson HB
    Curr Top Behav Neurosci; 2010; 2():527-43. PubMed ID: 21309125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of antipsychotics in obsessive compulsive disorder.
    Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM
    Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features, treatments and outcome of obsessive-compulsive disorder (OCD) focusing on the assessment and characteristics of patients with treatment-refractory OCD].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2013; 115(9):967-74. PubMed ID: 24228474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 33. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation.
    Husted DS; Shapira NA
    CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
    Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
    J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating OCD: what to do when first-line therapies fail.
    Castle D; Bosanac P; Rossell S
    Australas Psychiatry; 2015 Aug; 23(4):350-3. PubMed ID: 26104775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature.
    Pepper J; Hariz M; Zrinzo L
    J Neurosurg; 2015 May; 122(5):1028-37. PubMed ID: 25635480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the pharmacological options for pediatric obsessive-compulsive disorder.
    Marazziti D; Pozza A
    Expert Opin Pharmacother; 2022 Nov; 23(16):1793-1800. PubMed ID: 36310087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach.
    Uguz F
    Braz J Psychiatry; 2015; 37(4):334-42. PubMed ID: 26692431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory obsessive-compulsive disorder: state-of-the-art treatment.
    Hollander E; Bienstock CA; Koran LM; Pallanti S; Marazziti D; Rasmussen SA; Ravizza L; Benkelfat C; Saxena S; Greenberg BD; Sasson Y; Zohar J
    J Clin Psychiatry; 2002; 63 Suppl 6():20-9. PubMed ID: 12027116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.